— Know what they know.
Not Investment Advice

SYBX OTC

Synlogic, Inc.
1W: -2.6% 1M: -9.0% 3M: +58.4% YTD: -5.1% 1Y: -33.5% 3Y: -77.6% 5Y: -97.7%
$1.11
-0.01 (-0.89%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 43 · $13.0M mcap · 6M float · 0.853% daily turnover · Short 24% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$13.0M
52W Range0.54-1.87
Volume4,008
Avg Volume54,641
Beta0.51
Dividend—
Analyst Ratings
10 Buy 3 Hold 1 Sell
Consensus Buy
Company Info
CEOMary Beth Dooley
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2015-09-30
PO Box 30
Winchester, MA 01890
US
617 401 9975
About Synlogic, Inc.

Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.

Recent Insider Trades

NameTypeSharesPriceDate
New Enterprise Assoc P-Purchase 2,640,845 $0.70 2026-07-27
Dooley Mary Beth S-Sale 157 $1.81 2025-10-29
Shea Richard P A-Award 15,000 — 2025-04-26
Flynn James P A-Award 15,000 — 2025-04-26
Dooley Mary Beth S-Sale 144 $1.20 2025-04-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms